Follow
Anna M. Wu
Anna M. Wu
Professor and Chair, Immunology & Theranostics, City of Hope
Verified email at coh.org
Title
Cited by
Cited by
Year
Quantum dots for live cells, in vivo imaging, and diagnostics
X Michalet, FF Pinaud, LA Bentolila, JM Tsay, S Doose, JJ Li, ...
science 307 (5709), 538-544, 2005
96602005
Arming antibodies: prospects and challenges for immunoconjugates
AM Wu, PD Senter
Nature biotechnology 23 (9), 1137-1146, 2005
14112005
Minibody: A Novel Engineered Anti-Carcinoembryonic Antigen Antibody Fragment (Single-Chain Fv-CH3) Which Exhibits Rapid, High-Level Targeting of Xenografts
S Hu, L Shively, A Raubitschek, M Sherman, LE Williams, JYC Wong, ...
Cancer research 56 (13), 3055-3061, 1996
6031996
Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice
ML Schipper, G Iyer, AL Koh, Z Cheng, Y Ebenstein, A Aharoni, S Keren, ...
Small 5 (1), 126-134, 2009
5112009
Consensus guided mutagenesis of Renilla luciferase yields enhanced stability and light output
AM Loening, TD Fenn, AM Wu, SS Gambhir
Protein Engineering, Design and Selection 19 (9), 391-400, 2006
5102006
The complete nucleotide sequence of the tryptophan operon of Escherichia coli
C Yanofsky, T Platt, IP Crawford, BP Nichols, GE Christie, H Horowitz, ...
Nucleic acids research 9 (24), 6647-6668, 1981
4231981
Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression
J Lu, X Liu, YP Liao, F Salazar, B Sun, W Jiang, CH Chang, J Jiang, ...
Nature communications 8 (1), 1811, 2017
3842017
CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignancies
A Raubitschek, A Wu, MC Jensen
US Patent 6,410,319, 2002
3572002
Red-shifted Renilla reniformis luciferase variants for imaging in living subjects
AM Loening, AM Wu, SS Gambhir
Nature methods 4 (8), 641-643, 2007
3522007
Antibody vectors for imaging
T Olafsen, AM Wu
Seminars in nuclear medicine 40 (3), 167-181, 2010
3182010
124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice
G Sundaresan, PJ Yazaki, JE Shively, RD Finn, SM Larson, ...
Journal of Nuclear Medicine 44 (12), 1962-1969, 2003
3072003
Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers
AM Wu, W Chen, A Raubitschek, LE Williams, M Neumaier, R Fischer, ...
Immunotechnology 2 (1), 21-36, 1996
3041996
Solution-phase surface modification in intact poly (dimethylsiloxane) microfluidic channels
G Sui, J Wang, CC Lee, W Lu, SP Lee, JV Leyton, AM Wu, HR Tseng
Analytical chemistry 78 (15), 5543-5551, 2006
2962006
An effective immuno-PET imaging method to monitor CD8-dependent responses to immunotherapy
R Tavaré, H Escuin-Ordinas, S Mok, MN McCracken, KA Zettlitz, ...
Cancer research 76 (1), 73-82, 2016
2942016
High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment
AM Wu, PJ Yazaki, S Tsai, K Nguyen, AL Anderson, DW McCarthy, ...
Proceedings of the National Academy of Sciences 97 (15), 8495-8500, 2000
2732000
Optical bioluminescence and positron emission tomography imaging of a novel fusion reporter gene in tumor xenografts of living mice
P Ray, AM Wu, SS Gambhir
Cancer research 63 (6), 1160-1165, 2003
2622003
Antibody construct
AM Wu
US Patent 5,837,821, 1998
2511998
In vivo imaging with antibodies and engineered fragments
AC Freise, AM Wu
Molecular immunology 67 (2), 142-152, 2015
2502015
microPET-based biodistribution of quantum dots in living mice
ML Schipper, Z Cheng, SW Lee, LA Bentolila, G Iyer, J Rao, X Chen, ...
Journal of Nuclear Medicine 48 (9), 1511-1518, 2007
2412007
Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti–carcinoembryonic antigen single-chain Fv-Fc antibody fragments
V Kenanova, T Olafsen, DM Crow, G Sundaresan, M Subbarayan, ...
Cancer research 65 (2), 622-631, 2005
2402005
The system can't perform the operation now. Try again later.
Articles 1–20